Document Detail


NGF-Dependent activation of TrkA pathway: A mechanism for the neuroprotective effect of troxerutin in D-galactose-treated mice.
MedLine Citation:
PMID:  20456366     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
D-galactose-(D-gal)-treated mouse, with cognitive impairment, has been used for neurotoxicity investigation and anti-neurotoxicity pharmacology research. In this study, we investigated the mechanism underlying the neuroprotective effect of troxerutin. The results showed that troxerutin improved behavioral performance in D-gal-treated mice by elevating Cu, Zn-superoxide dismutases (Cu, Zn-SOD) activity and decreasing reactive oxygen species levels. Furthermore, our results showed that troxerutin significantly promoted nerve growth factor (NGF) mRNA expression which resulted in TrkA activation. On one hand, NGF/TrkA induced activation of Akt and ERK1/2, which led to neuronal survival; on the other hand, NGF/TrkA mediated CaMKII and CREB phosphorylation and increased PSD95 expression, which improved cognitive performance. However, the neuroprotective effect of troxerutin was blocked by treatment with K252a, an antagonist for TrkA. No neurotoxicity was observed in mice treated with K252a or troxerutin alone. In conclusion, administration of troxerutin to D-gal-injected mice attenuated cognitive impairment and brain oxidative stress through the activation of NGF/TrkA signaling pathway.
Authors:
Jun Lu; Dong-mei Wu; Bin Hu; Yuan-lin Zheng; Zi-feng Zhang; Yong-jian Wang
Related Documents :
8706126 - Myelination in the absence of galactocerebroside and sulfatide: normal structure with a...
9501236 - Neural precursor differentiation into astrocytes requires signaling through the leukemi...
20127836 - Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystiti...
2432276 - Myelin-associated glycoprotein (mag) in the cns of adult shiverer (shi/shi) mice.
12193416 - Growth and differentiation factor-9 stimulates progression of early primary but not pri...
20231476 - Locus ceruleus controls alzheimer's disease pathology by modulating microglial function...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-03-19
Journal Detail:
Title:  Brain pathology (Zurich, Switzerland)     Volume:  20     ISSN:  1750-3639     ISO Abbreviation:  Brain Pathol.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-10     Completed Date:  2010-11-24     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  9216781     Medline TA:  Brain Pathol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  952-65     Citation Subset:  IM    
Affiliation:
Xuzhou Normal University, Jiangsu Province, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analysis of Variance
Animals
Avoidance Learning / drug effects
Behavior, Animal / drug effects
Brain / metabolism
CREB-Binding Protein / metabolism
Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
Carbazoles / pharmacology
Cognition Disorders / chemically induced,  pathology,  prevention & control*
Disease Models, Animal
Enzyme Inhibitors / pharmacology
Galactose / toxicity
Gene Expression Regulation / drug effects
Hydroxyethylrutoside / analogs & derivatives*,  therapeutic use
Indole Alkaloids / pharmacology
Intracellular Signaling Peptides and Proteins / metabolism
Male
Maze Learning / drug effects
Membrane Proteins / metabolism
Mice
Nerve Growth Factor / genetics,  pharmacology
Neuroprotective Agents / therapeutic use*
Reactive Oxygen Species / metabolism
Receptor, trkA / metabolism*
Signal Transduction / drug effects*
Superoxide Dismutase / metabolism
Chemical
Reg. No./Substance:
0/Carbazoles; 0/Enzyme Inhibitors; 0/Hydroxyethylrutoside; 0/Indole Alkaloids; 0/Intracellular Signaling Peptides and Proteins; 0/Membrane Proteins; 0/Neuroprotective Agents; 0/Reactive Oxygen Species; 26566-61-0/Galactose; 7085-55-4/troxerutin; 9061-61-4/Nerve Growth Factor; 97161-97-2/K 252; EC 1.15.1.1/Superoxide Dismutase; EC 2.3.1.48/CREB-Binding Protein; EC 2.7.10.1/Receptor, trkA; EC 2.7.11.17/Calcium-Calmodulin-Dependent Protein Kinase Type 2; EC 2.7.4.8/Dlgh4 protein, mouse

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are up...
Next Document:  Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell li...